Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason Valent

Showing results (51-60 of 81) with videos related to

Pageof 9
Sort By:
Ejhaem|May 18, 2026
Triplet or Quadruplet Regimen Utilization and Overall Survival in Patients Diagnosed With Multiple Myeloma Between 2017 and 2023Emily R Wesley, Faiz Anwer, Michael B Rothberg, et al.
British Journal of Haematology|May 17, 2021
Validation of the IMPEDE VTE score for prediction of venous thromboembolism in multiple myeloma: a retrospective cohort studyFahrettin Covut, Ramsha Ahmed, Sanchit Chawla, et al.
Cancer Research Communications|June 3, 2026
Multiple Myeloma Screening Education: A Community-Based Health Literacy InterventionKarie Feldman, Hong Li, Diana Basali, et al.
Blood Reviews|September 11, 2019
Treatment of relapsed multiple myeloma: Evidence-based recommendationsCeren Durer, Seren Durer, Sarah Lee, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 31, 2026
BIO26-048: A Meta-Analytic Evaluation of Efficacy and Safety Between Ide-cel and Cilta-cel in Relapsed/Refractory Multiple Myeloma Based on Clinical Trial and Real-World DataMobina Golmohammadi, Shahzad Raza, Doris K Hansen, et al.
Critical Reviews in Oncology/Hematology|June 18, 2022
Evidence-based recommendations for induction and maintenance treatment of newly diagnosed transplant-ineligible multiple myeloma patientsAbdul Rafae, Hamid Ehsan, Ahsan Wahab, et al.
International Journal of Molecular Sciences|June 19, 2024
Current Novel Targeted Therapeutic Strategies in Multiple MyelomaCindy Hsin-Ti Lin, Muhammad Junaid Tariq, Fauzia Ullah, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|July 3, 2024
Outcomes of venetoclax-based therapy in patients with t(11;14) light chain amyloidosis after failure of daratumumab-based therapyDanai Dima, Michael Hughes, Mark Orland, et al.
British Journal of Haematology|October 24, 2025
Current management of non-amyloidosis monoclonal gammopathy of renal significance: Clinical features, treatment selections, responses and renal outcomesDaniel Cancilla, Hanny Sawaf, Xuefei Jia, et al.
The American Journal of Cardiology|February 15, 2026
Estimated Stressed Blood Volume in Patients with Cardiac AmyloidosisSimon Vanhentenrijk, Silvio Nunes Augusto, Pieter Martens, et al.
Pageof 9

Showing results (51-60 of 81) with videos related to

Sort By:
Pageof 9
Ejhaem|May 18, 2026
Triplet or Quadruplet Regimen Utilization and Overall Survival in Patients Diagnosed With Multiple Myeloma Between 2017 and 2023Emily R Wesley, Faiz Anwer, Michael B Rothberg, et al.
British Journal of Haematology|May 17, 2021
Validation of the IMPEDE VTE score for prediction of venous thromboembolism in multiple myeloma: a retrospective cohort studyFahrettin Covut, Ramsha Ahmed, Sanchit Chawla, et al.
Cancer Research Communications|June 3, 2026
Multiple Myeloma Screening Education: A Community-Based Health Literacy InterventionKarie Feldman, Hong Li, Diana Basali, et al.
Blood Reviews|September 11, 2019
Treatment of relapsed multiple myeloma: Evidence-based recommendationsCeren Durer, Seren Durer, Sarah Lee, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 31, 2026
BIO26-048: A Meta-Analytic Evaluation of Efficacy and Safety Between Ide-cel and Cilta-cel in Relapsed/Refractory Multiple Myeloma Based on Clinical Trial and Real-World DataMobina Golmohammadi, Shahzad Raza, Doris K Hansen, et al.
Critical Reviews in Oncology/Hematology|June 18, 2022
Evidence-based recommendations for induction and maintenance treatment of newly diagnosed transplant-ineligible multiple myeloma patientsAbdul Rafae, Hamid Ehsan, Ahsan Wahab, et al.
International Journal of Molecular Sciences|June 19, 2024
Current Novel Targeted Therapeutic Strategies in Multiple MyelomaCindy Hsin-Ti Lin, Muhammad Junaid Tariq, Fauzia Ullah, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|July 3, 2024
Outcomes of venetoclax-based therapy in patients with t(11;14) light chain amyloidosis after failure of daratumumab-based therapyDanai Dima, Michael Hughes, Mark Orland, et al.
British Journal of Haematology|October 24, 2025
Current management of non-amyloidosis monoclonal gammopathy of renal significance: Clinical features, treatment selections, responses and renal outcomesDaniel Cancilla, Hanny Sawaf, Xuefei Jia, et al.
The American Journal of Cardiology|February 15, 2026
Estimated Stressed Blood Volume in Patients with Cardiac AmyloidosisSimon Vanhentenrijk, Silvio Nunes Augusto, Pieter Martens, et al.
Pageof 9